International comparative epidemiology of idiopathic pulmonary fibrosis

QR Code

International comparative epidemiology of idiopathic pulmonary fibrosis

Background Evidence from the UK suggests the incidence of idiopathic pulmonary fibrosis is increasing, but there is a lack of data from elsewhere in the World. The cause of the disease remains unknown. New anti-fibrotic therapies may increase the use of surgical lung biopsy for accurate diagnosis...

Full description

Bibliographic Details
Main Author:	Hutchinson, John
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2017
Subjects:	Pulmonary fibrosis; Epidemiology
Online Access:	https://eprints.nottingham.ac.uk/40715/

Similar Items

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century
by: Hutchinson, John P., et al.
Published: (2014)

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)

The role of Interleukin-33 in the development of idiopathic pulmonary fibrosis
by: Stephenson, Katherine
Published: (2021)

Preparation of potent and selective αvβ6 integrin inhibitors for the treatment of idiopathic pulmonary fibrosis and synthetic approaches towards the total synthesis of mescengricin
by: Robinson, Henry Duncan
Published: (2021)

Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council Dyspnea Grade
by: Kozu, R., et al.
Published: (2014)

Investigations into novel small molecules as potential treatments for idiopathic pulmonary fibrosis and malaria
by: Park, Jozef
Published: (2022)

The role of galectin-3 in the development of idiopathic pulmonary fibrosis
by: Parmar, Nimesh
Published: (2019)

cAMP mediated regulation of fibroblast to myofibroblast differentiation in idiopathic pulmonary fibrosis
by: Wright, Rebecca
Published: (2016)

Refining in-vivo models of pulmonary fibrosis
by: Habgood, Anthony
Published: (2018)

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Barratt, Shaney L., et al.
Published: (2018)

Interplay between EZH2 and G9a regulates CXCL10 gene repression in idiopathic pulmonary fibrosis
by: Coward, William R., et al.
Published: (2017)

The potential therapeutic effect of manipulating the extracellular matrix in idiopathic pulmonary fibrosis
by: Philp, Christopher J.
Published: (2016)

Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales
by: Steiner, Michael C., et al.
Published: (2017)

The role of mesenchymal G proteins in pulmonary fibrosis and lung development
by: Goodwin, Amanda T.
Published: (2021)

Application of a human primary epithelial-fibroblast co-culture system to study fibrosis
by: Richardson, Jaineeta
Published: (2017)

In vitro modelling of respiratory infections in idiopathic pulmonary fibrosis (IPF) using human induced pluripotent stem cell (hiPSCs)-derived alveolar epithelial type II cells
by: Serna Valverde, Ana Lilia
Published: (2023)

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
by: Jenkins, R. Gisli, et al.
Published: (2015)

Structure activity relationships of αv integrin antagonists for pulmonary fibrosis by variation in aryl substituents
by: Adams, James, et al.
Published: (2014)

Suberoylanilide hydroxamic acid – a potential epigenetic therapeutic agent for lung fibrosis?
by: Wang, Z., et al.
Published: (2009)

The epidemiology of hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations
by: Donaldson, James W.
Published: (2016)

Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis
by: Calver, J.F.
Published: (2023)

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
by: Hutchinson, John P., et al.
Published: (2016)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)

Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
by: Kuzu, R., et al.
Published: (2011)

Comorbidities and Medication Burden in Patients with Chronic Obstructive Pulmonary Disease Attending Pulmonary Rehabilitation
by: Noteboom, Ben, et al.
Published: (2014)

Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
by: Kozu, R., et al.
Published: (2011)

Potential false positive active extra pulmonary tuberculosis lesions on FDG PET/CT imaging in malignancy.
by: Jalil, Abdul Jalil, et al.
Published: (2010)

Double low-dose computed tomography pulmonary angiography in the diagnosis of pulmonary embolism
by: Sun, Zhonghua, et al.
Published: (2019)

Multimorbidity in patients with COPD and pulmonary rehabilitation
by: Hakamy, Ali
Published: (2018)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

The impact of elevated pulmonary artery pressure on exercise responses
by: Fowler, Robin
Published: (2012)

Paramedic identification of acute pulmonary edema In a metropolitan ambulance service
by: Williams, Teresa, et al.
Published: (2013)

Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
by: Dalleywater, William, et al.
Published: (2014)

Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
by: Pasini, Alice, et al.
Published: (2016)

Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
by: Pasini, Alice, et al.
Published: (2016)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

Xbox Kinect™ represents high intensity exercise for adults with cystic fibrosis
by: Holmes, H., et al.
Published: (2013)

Biomarkers of progressive lung fibrosis
by: Khan, Fasihul
Published: (2022)